SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Supriya Lifescience informs about press release

03 Oct 2022 Evaluate
Pursuant to the relevant provisions of the SEBI Listing Regulations, Supriya Lifescience has informed that it enclosing Press Release for Appointment of Rajeev Kumar Jain as Chief Executive Officer & Key Managerial Personnel with effective from October 3, 2022.

The above information is a part of company’s filings submitted to BSE.

Supriya Lifescience Share Price

662.35 5.45 (0.83%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.85
Dr. Reddys Lab 1333.05
Cipla 1305.85
Zydus Lifesciences 947.10
Lupin 2340.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×